REFERENCES
- Boynton JR, Rounds MF, Quatela VC, Brown MD. The significance of positive margins (known and unknown) at the conclusion of Mohs’ surgery in the orbital region. Ophthal Plast Reconstr Surg 1996; 12: 51–57
- Burkert J, Wright NA, Alison MR. Stem cells and cancer: An intimate relationship. J Pathol 2006; 209: 287–297
- Madani S, Huilgol SC, Carruthers C. Unplanned incomplete Mohs’ micrographic surgery. J Am Acad Dermatol. 2000; 42: 814–819
- Malhotra R, Huilgol SC, Huynh NT, et al. The Australian Mohs’ Database II: Periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology 2004; 111: 631–636
- Nemet AY, Deckel Y, Martin PA, et al. Management of periocular basal and squamous cell carcinoma: A series of 485 cases. Am J Ophthalmol 2006; 142: 293–297
- Robins P, Rodriguez-Sains R, Rabinovitz H, et al. Mohs’ surgery for periocular basal cell carcinomas. J Dermatol Surg Oncol 1985; 11: 1203–1207
- Rowe DE, Caroll RJ, Day CL. Mohs’ surgery is the treatment of choice for recurrent (previously treated) BCC. J Dermatol Surg Oncol. 1989; 15: 424–431
- Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. J Am Acad Dermatol 1990; 23: 1118–1126